Article
Heterogeneity of Multiple System Atrophy: An Update
3 Mar 2022
Abstract excerpt
Multiple system atrophy (MSA) is a fatal, rapidly progressing neurodegenerative disease of uncertain etiology, clinically characterized by various combinations of Levodopa unresponsive parkinsonism, cerebellar, autonomic and motor dysfunctions. The morphological hallmark of this α-synucleinopathy is the deposition of aberrant α-synuclein in both glia, mainly oligodendroglia (glial cytoplasmic inclusions /GCIs/)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
